MEDICAMENTOS EXCLUSIVOS: EMICIZUMAB (HEMLIBRA), OCRELIZUMAB (OCREVUS), COBIMETINIB (COTELLIC), VEMURAFENIB (ZELBORAF)
Tender information
TED EUMadrid, Spain
- Type
- 29
- Procedure
- neg-wo-call
- Ref. number
- 240315-2024
- Estimated value
- 1,030,399 EUR
- CPV
- 33600000
MEDICAMENTOS EXCLUSIVOS: EMICIZUMAB (HEMLIBRA), OCRELIZUMAB (OCREVUS), COBIMETINIB (COTELLIC), VEMURAFENIB (ZELBORAF)